Luís Costa

8.4k total citations · 2 hit papers
181 papers, 5.7k citations indexed

About

Luís Costa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Luís Costa has authored 181 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Oncology, 69 papers in Pulmonary and Respiratory Medicine and 53 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Luís Costa's work include Bone health and treatments (63 papers), Radiopharmaceutical Chemistry and Applications (43 papers) and Cancer Diagnosis and Treatment (27 papers). Luís Costa is often cited by papers focused on Bone health and treatments (63 papers), Radiopharmaceutical Chemistry and Applications (43 papers) and Cancer Diagnosis and Treatment (27 papers). Luís Costa collaborates with scholars based in Portugal, United States and United Kingdom. Luís Costa's co-authors include Allan Lipton, Sandra Casimiro, Laurence M. Demers, Roger von Moos, Robert E. Coleman, Irina Alho, Pierre Major, Edward Chow, Jean‐Jacques Body and Giorgio V. Scagliotti and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Luís Costa

174 papers receiving 5.6k citations

Hit Papers

Randomized, Double-Blind Study of Denosumab Versus Zoledr... 2011 2026 2016 2021 2011 2020 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
    2011 877 citations Luís Costa et al. profile →
  2. Bone metastases
    2020 347 citations Luís Costa et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luís Costa Portugal 38 3.9k 1.5k 1.5k 1.4k 944 181 5.7k
Ingo Diel Germany 36 5.1k 1.3× 1.2k 0.8× 1.0k 0.7× 1.6k 1.2× 930 1.0× 113 6.5k
Catherine Van Poznak United States 39 5.2k 1.3× 1.7k 1.1× 1.3k 0.9× 1.1k 0.8× 764 0.8× 150 7.3k
Matthew R. Smith United States 27 2.9k 0.7× 3.4k 2.2× 712 0.5× 1.4k 1.0× 777 0.8× 72 5.4k
Carsten Goessl United States 32 6.2k 1.6× 4.5k 2.9× 3.1k 2.1× 1.5k 1.1× 954 1.0× 114 9.7k
Monica Fornier United States 34 2.5k 0.6× 916 0.6× 889 0.6× 558 0.4× 213 0.2× 110 3.9k
G. David Roodman United States 45 5.3k 1.3× 899 0.6× 3.1k 2.1× 846 0.6× 774 0.8× 130 7.7k
Per‐Anders Abrahamsson Sweden 39 1.3k 0.3× 3.4k 2.2× 1.3k 0.9× 572 0.4× 640 0.7× 111 5.5k
Alfredo Berruti Italy 43 2.5k 0.6× 1.5k 1.0× 1.3k 0.9× 753 0.5× 2.6k 2.8× 245 7.4k
Mark L. Graham United States 26 2.2k 0.6× 574 0.4× 1.3k 0.9× 298 0.2× 272 0.3× 53 4.5k
Peter J. Van Veldhuizen United States 34 1.4k 0.4× 1.3k 0.8× 1.4k 1.0× 318 0.2× 374 0.4× 96 3.6k

Countries citing papers authored by Luís Costa

Since Specialization
Citations

This map shows the geographic impact of Luís Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luís Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luís Costa more than expected).

Fields of papers citing papers by Luís Costa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luís Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luís Costa. The network helps show where Luís Costa may publish in the future.

Co-authorship network of co-authors of Luís Costa

This figure shows the co-authorship network connecting the top 25 collaborators of Luís Costa. A scholar is included among the top collaborators of Luís Costa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luís Costa. Luís Costa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martins, Diana, Ana Marques, Luís Pacheco‐Figueiredo, et al.. (2024). Biomarker Profiling of Upper Tract Urothelial Carcinoma Only and with Synchronous or Metachronous Bladder Cancer. Biomedicines. 12(9). 2154–2154. 1 indexed citations
2.
Antunes, Marília, et al.. (2023). Clinical Validation of a Size-Based Microfluidic Device for Circulating Tumor Cell Isolation and Analysis in Renal Cell Carcinoma. International Journal of Molecular Sciences. 24(9). 8404–8404. 5 indexed citations
3.
Pérez, Vanessa, et al.. (2023). Immunotherapy around the Clock: Impact of Infusion Timing on Stage IV Melanoma Outcomes. Cells. 12(16). 2068–2068. 17 indexed citations
4.
Teixeira, Laetitia, Susana Sousa, Joana Reis, et al.. (2023). 360 Health Analysis (H360)—A Comparison of Key Performance Indicators in Breast Cancer Management across Health Institution Settings in Portugal. Current Oncology. 30(7). 6041–6065. 1 indexed citations
5.
Patel, Vijay, Lino Gonçalves, Ruffo Freitas‐Júnior, et al.. (2023). P11.54.A BRAIN RELAPSE IN HER2-POSITIVE BREAST CANCER AFTER NEOADJUVANT TREATMENT: AN INTERNATIONAL MULTICENTRIC STUDY. Neuro-Oncology. 25(Supplement_2). ii86–ii86. 1 indexed citations
6.
Mota, Joana, Sandra Casimiro, Renata Minuzzo Hartmann, et al.. (2022). Lupin Protein Concentrate as a Novel Functional Food Additive That Can Reduce Colitis-Induced Inflammation and Oxidative Stress. Nutrients. 14(10). 2102–2102. 10 indexed citations
7.
Mota, Joana, et al.. (2022). Therapeutic Potential of Deflamin against Colorectal Cancer Development and Progression. Cancers. 14(24). 6182–6182. 3 indexed citations
8.
Martins, Marta, et al.. (2022). Kidney Cancer Biomarker Selection Using Regularized Survival Models. Cells. 11(15). 2311–2311. 1 indexed citations
9.
Costa, Diogo Alpuim, Marta Vaz Batista, Catarina Ribeiro, et al.. (2021). Human Microbiota and Breast Cancer—Is There Any Relevant Link?—A Literature Review and New Horizons Toward Personalised Medicine. Frontiers in Microbiology. 12. 584332–584332. 85 indexed citations
10.
Costa, Luís, et al.. (2021). MicroRNA‐181a restricts human γδ T cell differentiation by targeting Map3k2 and Notch2. EMBO Reports. 23(1). e52234–e52234. 12 indexed citations
11.
Abalde‐Cela, Sara, et al.. (2021). HER2 Expression in Circulating Tumour Cells Isolated from Metastatic Breast Cancer Patients Using a Size-Based Microfluidic Device. Cancers. 13(17). 4446–4446. 32 indexed citations
12.
Ferreira, Arlindo R., Vasco Sanchez Rodrigues, Ana Miranda, et al.. (2017). Treatment adoption and relative effectiveness of aromatase inhibitors compared to tamoxifen in early breast cancer: A multi-institutional observational study. The Breast. 37. 107–113. 7 indexed citations
13.
Mendes, Diogo, Carlos Alves, N. Afonso, et al.. (2015). The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review. Breast Cancer Research. 17(1). 140–140. 143 indexed citations
14.
Pakala, Suresh B., Suresh K. Rayala, Rui‐An Wang, et al.. (2013). MTA1 Promotes STAT3 Transcription and Pulmonary Metastasis in Breast Cancer. Cancer Research. 73(12). 3761–3770. 55 indexed citations
15.
Casimiro, Sandra, et al.. (2011). Analysis of a bone metastasis gene expression signature in patients with bone metastasis from solid tumors. Clinical & Experimental Metastasis. 29(2). 155–164. 43 indexed citations
16.
17.
Vítor, Rute F., Teresa Esteves, Fernanda Marques, et al.. (2009). 99m Tc-Tricarbonyl Complexes Functionalized with Anthracenyl Fragments: Synthesis, Characterization, and Evaluation of Their Radiotoxic Effects in Murine Melanoma Cells. Cancer Biotherapy and Radiopharmaceuticals. 24(5). 551–563. 22 indexed citations
18.
Costa, Luís & Pierre Major. (2009). Effect of bisphosphonates on pain and quality of life in patients with bone metastases. Nature Reviews Clinical Oncology. 6(3). 163–174. 137 indexed citations
19.
Costa, Luís. (2004). Las rumbas olvidadas: transculturalidad y etnicización en la música popular gallega. 0. 1 indexed citations
20.
Lipton, Allan, L. Demers, Vernon M. Chinchilli, et al.. (1998). Markers of bone resorption in patients treated with pamidronate. European Journal of Cancer. 34(13). 2021–2026. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ingo Diel Breakdown of academic impact, for papers by Catherine Van Poznak Breakdown of academic impact, for papers by Matthew R. Smith Breakdown of academic impact, for papers by Carsten Goessl Breakdown of academic impact, for papers by Monica Fornier Breakdown of academic impact, for papers by G. David Roodman Breakdown of academic impact, for papers by Per‐Anders Abrahamsson Breakdown of academic impact, for papers by Alfredo Berruti Breakdown of academic impact, for papers by Mark L. Graham Breakdown of academic impact, for papers by Peter J. Van Veldhuizen
Rankless by CCL
2026